Lifeward wins FDA nod for next-gen exoskeleton
March 13, 2025
Lifeward (Nasdaq:LFWD) announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk 7.
Lifeward (Nasdaq:LFWD) announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk 7.
Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic navigation.
Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.
Johnson & Johnson MedTech (NYSE: JNJ)+
announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy.
Spinal cord injuries are life-altering, often leaving individuals with severe mobility impairments. While rehabilitation robotics—devices that guide movement during therapy—have improved training for those with spinal cord injuries, their effectiveness remains limited. Without active muscle engagement, robotic-assisted movement alone does not sufficiently retrain the nervous system.
Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic platform.
Exactech this week announced the first surgical procedures using its Vantage Ankle 3D and 3D+ tibial implants with GPS Ankle navigation.
Think Surgical today announced the first successful use of Waldemar Link’s LinkSymphoKnee using the TMINI Miniature Robotic System.
Ronovo Surgical has received regulatory approval for its Carina surgical robotic platform in China.
Researchers at UC San Francisco have enabled a man who is paralyzed to control a robotic arm through a device that relays signals from his brain to a computer.